News | Radiation Therapy | May 20, 2016

Elekta Surpasses 1 Million Patients Treated with Leksell Gamma Knife

Latest iteration of stereotactic and radiation therapy platform to be installed at five new sites in coming months

May 20, 2016 — At the 18th International Leksell Gamma Knife Society Meeting in Amsterdam, May 15-19, Elekta announced the Leksell Gamma Knife radiosurgery system has been used in the treatment of more than 1 million patients. The system has been used on patients afflicted with brain tumors, vascular malformations and functional disorders.

Today, Gamma Knife surgery is performed on more than 75,000 patients every year in hundreds of hospitals and clinics around the world. The average clinical volume per treatment site has also steadily grown each year due to a proliferation of supporting clinical evidence and product enhancements that improve clinical efficiency.

Leksell Gamma Knife Icon, the newest generation of the system, is currently being used to treat patients in Europe, the United States and Asia. Icon expands on the capabilities of Gamma Knife, while providing additional frameless flexibility for either accurate single-dose administration or fractionated multiple treatment sessions over time, enabling treatment of larger tumor volumes, targets close to critical brain structures and new or recurring brain metastases.

In the coming months, installations of Icon are planned at several leading centers including The University of Texas MD Anderson Cancer Center (Houston), University of Pittsburgh Medical Center (Pittsburgh), University of Virginia Health System (Charlottesville, Va.), The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (Amsterdam, Netherlands) and Centre Hospitalier Universitaire Vaudois (Lausanne, Switzerland).

Metastatic brain tumors and other neurological disorders negatively impact survival and quality of life in a large and growing patient population. Worldwide, more than 256,000 new cases of brain and other central nervous system (CNS) tumors are diagnosed annually, with an estimated 189,000 deaths.

“Gamma Knife radiosurgery is a proven approach that has helped us resolve complex brain lesions, vascular complications and other neurological abnormalities, many of which were previously thought to be inoperable,” said Jean Regis, M.D., neurosurgeon and Gamma Knife program director, University Hospital La Timone, Marseille, France, who has performed more than 16,000 Gamma Knife procedures. “Over the past four decades, we’ve established a wide body of clinical evidence supporting Gamma Knife radiosurgery in the treatment of diverse brain and central nervous system pathologies, and in my experience, this is an attractive option for patients and clinicians, enabling a significant reduction in radiation exposure to healthy tissue and a negligible post-procedural convalescence period where the typical patient can usually leave the hospital within an hour.”

Douglas Kondziolka, M.D., a researcher and neurosurgeon who has performed many thousands of Gamma Knife procedures, added “Gamma Knife radiosurgery is an excellent example of how evolving cancer care technologies are addressing growing demand for precision medicine, where treatments can be precisely tailored to an individual’s unique anatomy and biologic makeup while simultaneously helping to reduce the risk of damaging healthy tissue. As one of the most comprehensively studied tools in the neurosurgery armamentarium, we can confidently offer this treatment option as a minimally invasive alternative to traditional brain surgery or whole brain radiation therapy for properly selected patients.”

“Receiving a brain tumor diagnosis is nothing short of shocking, but I feel incredibly fortunate to have discovered an effective alternative to traditional open surgery,” said Josh Perry, 27-year-old pro BMX athlete who underwent an open craniotomy for a meningioma and then received Gamma Knife to treat a recurrence several years later. “In contrast to my first procedure, which took six hours and required a two month recovery, I was up and talking minutes after receiving Gamma Knife and back on my bike within a week.”

Stereotactic radiosurgery is a non-invasive alternative to traditional brain surgery and radiation therapy for the treatment of complex, difficult to treat brain conditions. Using up to 192 precisely focused sources of radiation, Gamma Knife controls malignant and nonmalignant tumors, as well as arteriovenous malformations, essential tremor and trigeminal neuralgia while limiting damage to healthy tissue. The extremely high precision of Gamma Knife surgery is achieved using a three-dimensional coordinate system to locate and treat small targets inside the head.

For more information:

Related Content

Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
ASTRO Applauds Introduction of PIMA Patient Protection Bill
News | Radiology Business | April 15, 2019
The American Society for Radiation Oncology (ASTRO) hailed the introduction of federal legislation that would...
Varian Discloses First Preclinical Results of Flash Therapy in Cancer Treatment
News | Proton Therapy | April 09, 2019
Varian, in partnership with the University of Maryland School of Medicine’s Department of Radiation Oncology and the...
Varian Halcyon Commissioned at MedStar Southern Maryland Hospital Center With IBA's myQA Halo
News | Quality Assurance (QA) | April 04, 2019
IBA (Ion Beam Applications S.A.) announced the successful commissioning of the Varian Halcyon at the Radiation Oncology...
Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill. Interview with Mark Pankuch, Ph.D.

Four of the top pieces of content in March included news on proton therapy, including a 360 image and videos from ITN's recent visit to the Northwestern Medicine Proton Center in the Chicago suburbs. This image shows the main proton treatment room gantry at the proton center in Warrenville, Ill.

Feature | April 02, 2019 | Dave Fornell, Editor and A.J. Connell
April 2, 2019 — Here is the list of the most popular content on the Imaging Technology News (ITN) magazine w
ZON-PTC in Clinical Use With RayStation 8B and Hyperscan
News | Treatment Planning | March 19, 2019
Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient...
What to Expect from the Proton Therapy Market in 2019-2020
News | Proton Therapy | March 13, 2019
The number of new particle therapy rooms ordered worldwide dropped by almost 20 percent in 2018, according to a new...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...